Summary & Overview
HCPCS Level II J7351: Bimatoprost Intracameral Implant, 1 mcg
HCPCS Level II code J7351 denotes the intracameral injection of a bimatoprost implant (1 microgram) used in ophthalmic care. This code captures a procedure-level pharmaceutical implant administered directly into the eye and is relevant for procedural billing in ambulatory surgical centers and ophthalmology clinics. Nationally, accurate coding for device-based intraocular drug delivery affects coverage determinations, prior authorization workflows, and facility reimbursement for ophthalmic procedures.
Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise presentation of what the code represents clinically and operationally, plus an outline of payer coverage patterns and benchmarking considerations where available. The publication highlights typical sites of service, billing context for implantable ophthalmic agents, and common modifier usage (listed separately), helping billing managers and compliance teams align claims submission to payer expectations.
The article provides practical reference material: a clear code description, expected clinical setting, and where to look for payer policy updates and coverage criteria. Data not available in the input is identified explicitly in relevant sections elsewhere in the publication.
Billing Code Overview
HCPCS Level II code J7351 represents an injection of bimatoprost intracameral implant, sized at 1 microgram. The service is an intracameral ophthalmic implant administration, reflecting a targeted intraocular therapeutic procedure.
Service Type: Intracameral implant injection
Typical Site of Service: Eye/ophthalmology procedure setting, such as an ambulatory surgical center or ophthalmology clinic with procedural capability.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with medically uncontrolled primary open-angle glaucoma despite maximum tolerated topical therapy presents to an ophthalmology clinic for minimally invasive intraocular pressure (IOP) management. The ophthalmologist performs an in-office or ambulatory surgical center procedure to insert a J7351 bimatoprost intracameral implant (1 microgram) into the anterior chamber. The clinical workflow includes pre-procedure evaluation (visual acuity, IOP measurement, slit-lamp exam, gonioscopy), informed consent, topical or local anesthesia, aseptic preparation, intracameral implant delivery via a single-use applicator, immediate post-procedure IOP check, short observation for complications (pain, hemorrhage, hyphema, elevated IOP), and scheduling follow-up visits at 1 day, 1 week, and 1–3 months for IOP monitoring and implant assessment. Typical sites of service are ophthalmology clinic procedure rooms, ambulatory surgical centers, or hospital outpatient departments. Common clinical goals are sustained IOP reduction and decreased reliance on topical glaucoma medications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default service or no modifier required | Use when no other modifier applies and the service is routine |